Nencini P
Institute of Medical Pharmacology, University La Sapienza, Rome, Italy.
Pharmacol Biochem Behav. 1988 Jul;30(3):755-64. doi: 10.1016/0091-3057(88)90095-0.
To study the role played by opiate mechanisms in the tolerance to the anorectic effects of amphetamines, the influence of chronic treatment with d,1-amphetamine (AMPH) on the effects of the selective kappa opiate agonist U50488H (U50), of morphine (MORPH) and of diazepam (DZP) on food and water intake was evaluated in rats. Since diuresis is selectively enhanced by kappa agonists, its sensitivity to chronic AMPH was also evaluated. On the first day of AMPH treatment the feeding response to U50 was depressed. On day 9, when tolerance to the anorectic effects of AMPH had developed, this response was enhanced and prolonged. U50-mediated diuresis was not increased in the AMPH group. AMPH however produced diuresis by itself and this effect may be responsible for the increased water intake that developed during chronic treatment. The administration of MORPH (on day 17), but not of DZP (on day 13), produced a similar pattern of response. Interruption of AMPH treatment brought about a slow normalization of response to U50, that appeared to be completed after 17 days. An increase in feeding response to U50 was also obtained after 14 days of cathinone administration, confirming the amphetamine-like properties of this drug. In order to evaluate the possibility that preventing sensitization of opiate mechanisms could also prevent tolerance to anorectic effects of AMPH, we chronically administered MORPH in combination with AMPH, obtaining a further reduction of feeding and an apparent slowing in tolerance development. However, such a reduction was also obtained acutely, although MORPH alone produced feeding stimulation. We suggest that opiates may both activate and inhibit feeding and that AMPH inhibits the activatory branch and works synergically with the inhibitory branch. The prolonged inhibition of the activatory branch causes its compensatory hypertrophy resulting in hypersensitivity to exogenous opiates.
为研究阿片机制在对苯丙胺类药物厌食作用耐受性中所起的作用,评估了大鼠长期接受消旋苯丙胺(AMPH)治疗对选择性κ阿片受体激动剂U50488H(U50)、吗啡(MORPH)和地西泮(DZP)对食物和水摄入量影响的作用。由于κ激动剂可选择性增强利尿作用,因此还评估了其对长期AMPH的敏感性。在AMPH治疗的第一天,对U50的摄食反应受到抑制。在第9天,当对AMPH的厌食作用产生耐受性时,这种反应增强且持续时间延长。AMPH组中U50介导的利尿作用并未增强。然而,AMPH本身会产生利尿作用,这种作用可能是长期治疗期间饮水量增加的原因。给予MORPH(第17天)而非DZP(第13天)产生了类似的反应模式。停止AMPH治疗后,对U50的反应缓慢恢复正常,这一过程在17天后似乎完成。服用卡西酮14天后,对U50的摄食反应也增加,证实了该药物具有苯丙胺样特性。为评估阻止阿片机制致敏是否也能阻止对AMPH厌食作用的耐受性,我们将MORPH与AMPH联合长期给药,结果摄食量进一步减少,耐受性发展明显减慢。然而,单独使用MORPH会产生摄食刺激,但急性给予二者也会出现这种减少。我们认为,阿片类药物可能既激活又抑制摄食,而AMPH抑制激活分支并与抑制分支协同作用。激活分支的长期抑制导致其代偿性肥大,从而对外源性阿片类药物产生超敏反应。